# Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

> **NCT06233526** · NA · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Acute Myeloid Leukemia in Children

## Interventions

- **OTHER:** Chemotherapy regiments based on the transcriptomic profile and in vitro drug sensitivity test

## Key facts

- **NCT ID:** NCT06233526
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06233526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06233526, "Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06233526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*